Cargando…

Neuropathologic Implication of Peripheral Neuregulin-1 and EGF Signals in Dopaminergic Dysfunction and Behavioral Deficits Relevant to Schizophrenia: Their Target Cells and Time Window

Neuregulin-1 and epidermal growth factor (EGF) are implicated in the pathogenesis of schizophrenia. To test the developmental hypothesis for schizophrenia, we administered these factors to rodent pups, juveniles, and adults and characterized neurobiological and behavioral consequences. These factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Nawa, Hiroyuki, Sotoyama, Hidekazu, Iwakura, Yuriko, Takei, Nobuyuki, Namba, Hisaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052624/
https://www.ncbi.nlm.nih.gov/pubmed/24949465
http://dx.doi.org/10.1155/2014/697935
_version_ 1782320257851981824
author Nawa, Hiroyuki
Sotoyama, Hidekazu
Iwakura, Yuriko
Takei, Nobuyuki
Namba, Hisaaki
author_facet Nawa, Hiroyuki
Sotoyama, Hidekazu
Iwakura, Yuriko
Takei, Nobuyuki
Namba, Hisaaki
author_sort Nawa, Hiroyuki
collection PubMed
description Neuregulin-1 and epidermal growth factor (EGF) are implicated in the pathogenesis of schizophrenia. To test the developmental hypothesis for schizophrenia, we administered these factors to rodent pups, juveniles, and adults and characterized neurobiological and behavioral consequences. These factors were also provided from their transgenes or infused into the adult brain. Here we summarize previous results from these experiments and discuss those from neuropathological aspects. In the neonatal stage but not the juvenile and adult stages, subcutaneously injected factors penetrated the blood-brain barrier and acted on brain neurons, which later resulted in persistent behavioral and dopaminergic impairments associated with schizophrenia. Neonatally EGF-treated animals exhibited persistent hyperdopaminergic abnormalities in the nigro-pallido-striatal system while neuregulin-1 treatment resulted in dopaminergic deficits in the corticolimbic dopamine system. Effects on GABAergic and glutamatergic systems were transient or limited. Even in the adult stage, intracerebral administration and transgenic expression of these factors produced similar but not identical behavioral impairments, although the effects of intracerebral administration were reversible. These findings suggest that dopaminergic development is highly vulnerable to circulating ErbB ligands in the pre- and perinatal stages. Once maldevelopment of the dopaminergic system is established during early development, dopamine-associating behavioral deficits become irreversible and manifest at postpubertal stages.
format Online
Article
Text
id pubmed-4052624
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40526242014-06-19 Neuropathologic Implication of Peripheral Neuregulin-1 and EGF Signals in Dopaminergic Dysfunction and Behavioral Deficits Relevant to Schizophrenia: Their Target Cells and Time Window Nawa, Hiroyuki Sotoyama, Hidekazu Iwakura, Yuriko Takei, Nobuyuki Namba, Hisaaki Biomed Res Int Review Article Neuregulin-1 and epidermal growth factor (EGF) are implicated in the pathogenesis of schizophrenia. To test the developmental hypothesis for schizophrenia, we administered these factors to rodent pups, juveniles, and adults and characterized neurobiological and behavioral consequences. These factors were also provided from their transgenes or infused into the adult brain. Here we summarize previous results from these experiments and discuss those from neuropathological aspects. In the neonatal stage but not the juvenile and adult stages, subcutaneously injected factors penetrated the blood-brain barrier and acted on brain neurons, which later resulted in persistent behavioral and dopaminergic impairments associated with schizophrenia. Neonatally EGF-treated animals exhibited persistent hyperdopaminergic abnormalities in the nigro-pallido-striatal system while neuregulin-1 treatment resulted in dopaminergic deficits in the corticolimbic dopamine system. Effects on GABAergic and glutamatergic systems were transient or limited. Even in the adult stage, intracerebral administration and transgenic expression of these factors produced similar but not identical behavioral impairments, although the effects of intracerebral administration were reversible. These findings suggest that dopaminergic development is highly vulnerable to circulating ErbB ligands in the pre- and perinatal stages. Once maldevelopment of the dopaminergic system is established during early development, dopamine-associating behavioral deficits become irreversible and manifest at postpubertal stages. Hindawi Publishing Corporation 2014 2014-05-13 /pmc/articles/PMC4052624/ /pubmed/24949465 http://dx.doi.org/10.1155/2014/697935 Text en Copyright © 2014 Hiroyuki Nawa et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Nawa, Hiroyuki
Sotoyama, Hidekazu
Iwakura, Yuriko
Takei, Nobuyuki
Namba, Hisaaki
Neuropathologic Implication of Peripheral Neuregulin-1 and EGF Signals in Dopaminergic Dysfunction and Behavioral Deficits Relevant to Schizophrenia: Their Target Cells and Time Window
title Neuropathologic Implication of Peripheral Neuregulin-1 and EGF Signals in Dopaminergic Dysfunction and Behavioral Deficits Relevant to Schizophrenia: Their Target Cells and Time Window
title_full Neuropathologic Implication of Peripheral Neuregulin-1 and EGF Signals in Dopaminergic Dysfunction and Behavioral Deficits Relevant to Schizophrenia: Their Target Cells and Time Window
title_fullStr Neuropathologic Implication of Peripheral Neuregulin-1 and EGF Signals in Dopaminergic Dysfunction and Behavioral Deficits Relevant to Schizophrenia: Their Target Cells and Time Window
title_full_unstemmed Neuropathologic Implication of Peripheral Neuregulin-1 and EGF Signals in Dopaminergic Dysfunction and Behavioral Deficits Relevant to Schizophrenia: Their Target Cells and Time Window
title_short Neuropathologic Implication of Peripheral Neuregulin-1 and EGF Signals in Dopaminergic Dysfunction and Behavioral Deficits Relevant to Schizophrenia: Their Target Cells and Time Window
title_sort neuropathologic implication of peripheral neuregulin-1 and egf signals in dopaminergic dysfunction and behavioral deficits relevant to schizophrenia: their target cells and time window
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052624/
https://www.ncbi.nlm.nih.gov/pubmed/24949465
http://dx.doi.org/10.1155/2014/697935
work_keys_str_mv AT nawahiroyuki neuropathologicimplicationofperipheralneuregulin1andegfsignalsindopaminergicdysfunctionandbehavioraldeficitsrelevanttoschizophreniatheirtargetcellsandtimewindow
AT sotoyamahidekazu neuropathologicimplicationofperipheralneuregulin1andegfsignalsindopaminergicdysfunctionandbehavioraldeficitsrelevanttoschizophreniatheirtargetcellsandtimewindow
AT iwakurayuriko neuropathologicimplicationofperipheralneuregulin1andegfsignalsindopaminergicdysfunctionandbehavioraldeficitsrelevanttoschizophreniatheirtargetcellsandtimewindow
AT takeinobuyuki neuropathologicimplicationofperipheralneuregulin1andegfsignalsindopaminergicdysfunctionandbehavioraldeficitsrelevanttoschizophreniatheirtargetcellsandtimewindow
AT nambahisaaki neuropathologicimplicationofperipheralneuregulin1andegfsignalsindopaminergicdysfunctionandbehavioraldeficitsrelevanttoschizophreniatheirtargetcellsandtimewindow